Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets.
about
The significance of genetics for cholangiocarcinoma developmentIntrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapiesGenetic profiling of intrahepatic cholangiocarcinomaMethylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary Cancer.MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytesComparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatographyLow doses of the carcinogen furan alter cell cycle and apoptosis gene expression in rat liver independent of DNA methylation.Isolated recurrence of distal adenocarcinoma of the extrahepatic bile duct on a draining sinus scar after curative resection: case report and review of the literatureLiver transplantation for non-hepatocellular carcinoma malignancy: Indications, limitations, and analysis of the current literature.Molecular mechanisms of cholangiocarcinoma.Aberrant DNA methylation profile in cholangiocarcinoma.Molecular pathogenesis of intrahepatic cholangiocarcinoma.MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.Physiogenomics in Etiopathogenesis of Cholangiocarcinoma.NcRNAs and Cholangiocarcinoma.Recent Advances in Understanding Cholangiocarcinoma.Molecular pathogenesis of cholangiocarcinoma
P2860
Q26865749-1E61C483-C992-4C5C-81E1-D182BB6E2A6AQ27002547-BEFE72E0-5E6E-413A-8E67-A8AC91704377Q27005787-4FDFE0EC-37A5-49F5-B188-4D822D116D48Q33955013-FF5C5CF2-2177-4305-90E6-959CF764B3BBQ34097997-3E30D1B1-8E16-400C-AEB5-FFECD0DB3F1AQ34239695-B74C7AFC-EABA-4B71-8C51-F54AC6E2E945Q34282873-12BCFF6C-5295-4F98-B1E4-A673775C26D3Q37651381-763260B6-B8C5-492C-9D81-4FD65554A1F1Q37777111-3B0A14CC-3843-43DA-A8E5-FB7E2C3B48DCQ37878879-70B89241-7477-42F0-9179-E516ADFA458CQ37878880-DD871F10-08C5-41AC-A6AD-77672AB2CD54Q38244965-736A8816-C010-4328-99A8-489DA155522BQ40337181-C1FE0236-8410-4D35-B5BB-AD080653FF68Q47143510-38CFA11F-EEB1-44CF-BD38-C967DFB2AD75Q47153848-3536A341-9BB8-4CD3-AC97-6FBE37F146B4Q47165549-2B448CCA-9923-4902-BDFF-0E27D898B6C7Q58704494-59F55344-885C-49D4-87C6-BE65EEB457CC
P2860
Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Epigenetic DNA hypermethylatio ...... fication of treatment targets.
@ast
Epigenetic DNA hypermethylatio ...... fication of treatment targets.
@en
type
label
Epigenetic DNA hypermethylatio ...... fication of treatment targets.
@ast
Epigenetic DNA hypermethylatio ...... fication of treatment targets.
@en
prefLabel
Epigenetic DNA hypermethylatio ...... fication of treatment targets.
@ast
Epigenetic DNA hypermethylatio ...... fication of treatment targets.
@en
P2093
P2860
P1433
P1476
Epigenetic DNA hypermethylatio ...... fication of treatment targets.
@en
P2093
Abdirashid M Shire
Dalbir S Sandhu
Lewis R Roberts
P2860
P356
10.1111/J.1478-3231.2007.01624.X
P577
2007-11-21T00:00:00Z